<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-630</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПОИСК И РАЗРАБОТКА НОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH AND DEVELOPMENT OF NEW DRUG PRODUCTS</subject></subj-group></article-categories><title-group><article-title>АНАЛИЗ ВЛИЯНИЯ СУБСТАНЦИЙ РАЗЛИЧНОЙ ПРИРОДЫ НА АКТИВНОСТЬ КАСПАЗ (ОБЗОР)</article-title><trans-title-group xml:lang="en"><trans-title>RESEARCH ON THE INFLUENCE OF VARIOUS SUBSTANCES ON CASPASE ACTIVITY (REVIEW)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кокарева</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kokareva</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozov</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Станишевский</surname><given-names>Я. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Stanishevskiy</surname><given-names>Ya. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubkov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов» (РУДН)</institution></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia (RUDN University)</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт вакцин и сывороток им. И. И. Мечникова» (ФГБНУ НИИВС им. И. И. Мечникова)</institution></aff><aff xml:lang="en"><institution>Federal State Budgetary Scientific Institution «Research Institute of Vaccines and Sera, I. I. Mechnikov's» (FSBSI RIVS I. I. Mechnikov's)</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>4</issue><fpage>29</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кокарева Е.С., Морозов В.В., Станишевский Я.М., Журавлева М.А., Зубков А.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кокарева Е.С., Морозов В.В., Станишевский Я.М., Журавлева М.А., Зубков А.В.</copyright-holder><copyright-holder xml:lang="en">Kokareva E.S., Morozov V.V., Stanishevskiy Y.M., Zhuravleva M.A., Zubkov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/630">https://www.pharmjournal.ru/jour/article/view/630</self-uri><abstract><p>В работе представлен обзор строения и функций ферментов семейства каспаз. Рассмотрены основные этапы и пути развития программируемой клеточной гибели - апоптоза. Продемонстрированы механизмы ингибирования и активации каспаз, и их роль в апоптозе клеток. Отдельные этапы активации каспаз в организме остаются ещё недостаточно исследованными. В настоящее время, подробно изучены строение, свойства, ключевые моменты функционирования и регуляции каспаз в организме, однако на молекулярном и клеточном уровнях, недостаточно для непосредственного регулирования их деятельности. Современные исследования влияния искусственно созданных субстанций различной природы на эти ферменты, в свою очередь, открывают перспективы для дальнейшего поиска методов их регуляции что, в свою очередь, позволило бы использовать полученные знания в лечении онкологических, аутоиммунных и нейродегенеративных заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>The paper presents an overview of the structure and functions of caspase group enzymes. The main stages and ways of development of programmed cell death - apoptosis were demonstrated. The mechanisms of inhibition and activation of caspasesand their role in cell apoptosis are demonstrated. The different stages of caspase activation in the body are still insufficiently studied. At present, the structure, properties, key points of the functioning and regulation of caspases in the body have been studied in detail, but at the molecular and cellular levels it is not enough to directly regulate their activity. Modern studies of the effect of artificially created substances of different nature on these enzymes, in turn, open up prospects for further search for methods of their regulation, which in turn would allow using the knowledge gained in the treatment of oncological, autoimmune and neurodegenerative diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>апоптоз</kwd><kwd>каспаза</kwd><kwd>нуклеотиды</kwd><kwd>субстанции нуклеотидно-пептидной природы</kwd><kwd>программируемая клеточная смерть</kwd></kwd-group><kwd-group xml:lang="en"><kwd>apoptosis</kwd><kwd>caspase</kwd><kwd>nucleotides</kwd><kwd>nucleotide-peptide substances</kwd><kwd>programmed cell death</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Владимирская Е. Б. Механизмы апоптотической смерти клеток. Гематология и трансфузиология. 2002. Т. 47. № 2. С. 35-40.</mixed-citation><mixed-citation xml:lang="en">Vladimirskaja E. B. Mechanisms of apoptotic cell death. Hematology and transfusiology. 2002. T. 47. № 2. P. 35-40.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьев М. Ю., Имянитов Е. Н., Хансон К. П. Апоптоз в норме и патологии. Медицинский академический журнал. 2003. Т. 3. № 3. С. 3-11.</mixed-citation><mixed-citation xml:lang="en">Grigor’ev M. Ju., Imjanitov E. N., Hanson K. P. Apoptosis is normal and pathological. Medical Academic Journal. T. 3. № 3. P. 3-11.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Нагорнев В. А., Восканьянц А. Н. Апоптоз и его роль в атерогенезе. Медицинский академический журнал. 2003. Т. 3. № 4. С. 3-18.</mixed-citation><mixed-citation xml:lang="en">Nagornev V. A., Voskan’janc A. N. Apoptosis and its role in atherogenesis. Medical Academic Journal. 2003. T. 3. № 4. P. 3-18.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Робинсон М. В., Труфакин В. А. Апоптоз клеток иммунной системы. Успехи современной биологии. 1991. Т. 3. Вып. 2. С. 246-259.</mixed-citation><mixed-citation xml:lang="en">Robinson M. V., Trufakin V. A. Apoptosis of cells of the immune system. Successes of modern biology. 1991. T. 3. Vyp. 2. P. 246-259.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez J., Lazebnik Y. Caspase-9 and Apaf-1 form an active holoenzyme. Genes Dev. 1999. № 13. Р. 3179-3184.</mixed-citation><mixed-citation xml:lang="en">Rodriguez J., Lazebnik Y. Caspase-9 and Apaf-1 form an active holoenzyme. Genes Dev. 1999. № 13. Р. 3179-3184.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Saleh A., Srinivasula S. M., Acharya S., Fishel R., Alnemri E. S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 1999. V. 274. P. 17941-17945.</mixed-citation><mixed-citation xml:lang="en">Saleh A., Srinivasula S. M., Acharya S., Fishel R., Alnemri E. S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 1999. V. 274. P. 17941-17945.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yang X., Chang H. Y., Baltimore D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science. 1998. V. 281. P. 1355-1357.</mixed-citation><mixed-citation xml:lang="en">Yang X., Chang H. Y., Baltimore D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science. 1998. V. 281. P. 1355-1357.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S., Doumanis J. The fly caspases. Cell Death Differ. 2000. № 7. Р. 1039-1044.</mixed-citation><mixed-citation xml:lang="en">Kumar S., Doumanis J. The fly caspases. Cell Death Differ. 2000. № 7. Р. 1039-1044.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y. Apoptosome: the cellular engine for the activation of caspase-9. Structure. 2002. № 10. Р. 285-288.</mixed-citation><mixed-citation xml:lang="en">Shi Y. Apoptosome: the cellular engine for the activation of caspase-9. Structure. 2002. № 10. Р. 285-288.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wei Y. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol. 2000. № 7. Р. 423-432.</mixed-citation><mixed-citation xml:lang="en">Wei Y. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol. 2000. № 7. Р. 423-432.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Salvesen G. S., Duckett C. S. IAP proteins: blocking the road to death’s door. Nature Rev. Mol. Cell Biol. 2002. № 3. Р. 401-410.</mixed-citation><mixed-citation xml:lang="en">Salvesen G. S., Duckett C. S. IAP proteins: blocking the road to death’s door. Nature Rev. Mol. Cell Biol. 2002. № 3. Р. 401-410.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sun C. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature. 1999. V. 401. P. 818-822.</mixed-citation><mixed-citation xml:lang="en">Sun C. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature. 1999. V. 401. P. 818-822.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ashhab Y., Alian A., Polliack A. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 2001. V. 495. P. 56-60.</mixed-citation><mixed-citation xml:lang="en">Ashhab Y., Alian A., Polliack A. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 2001. V. 495. P. 56-60.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zoog S. J., Schiller J. J., Wetter J. A. Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. EMBO J. 2002. V. 21. P. 5130-5140.</mixed-citation><mixed-citation xml:lang="en">Zoog S. J., Schiller J. J., Wetter J. A. Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. EMBO J. 2002. V. 21. P. 5130-5140.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Srinivasula S. M. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO mediates opposing effects on caspase activity and apoptosis. Nature. 2001. V. 409. P. 112-116.</mixed-citation><mixed-citation xml:lang="en">Srinivasula S. M. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO mediates opposing effects on caspase activity and apoptosis. Nature. 2001. V. 409. P. 112-116.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ. 2002. № 9. P. 93-95.</mixed-citation><mixed-citation xml:lang="en">Shi Y. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ. 2002. № 9. P. 93-95.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wu G. Structural basis of IAP recognition by Smac/DIABLO. Nature. 2000. V. 408. P. 1008-1012.</mixed-citation><mixed-citation xml:lang="en">Wu G. Structural basis of IAP recognition by Smac/DIABLO. Nature. 2000. V. 408. P. 1008-1012.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yang X., Chang H. Y., Baltimore D. Autoproteolytic activation of procaspases by oligomerization. Mol. Cell. 1998. № 1. Р. 319-325.</mixed-citation><mixed-citation xml:lang="en">Yang X., Chang H. Y., Baltimore D. Autoproteolytic activation of procaspases by oligomerization. Mol. Cell. 1998. № 1. Р. 319-325.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Boatright K. M., Salvesen G. S. Mechanisms of caspase activation. Boatright, Curr. Opin. Cell Biol. 2003. № 15. Р. 725-731.</mixed-citation><mixed-citation xml:lang="en">Boatright K. M., Salvesen G. S. Mechanisms of caspase activation. Boatright, Curr. Opin. Cell Biol. 2003. № 15. Р. 725-731.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Olivera S.-C. M., Caballero B. M., Argent R., Alonso J. C., Centeno F., Lorenzo M. J. JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3. Arch Biochem Biophys. 2017. № 15. V. 636. P. 42-49.</mixed-citation><mixed-citation xml:lang="en">Olivera S.-C. M., Caballero B. M., Argent R., Alonso J. C., Centeno F., Lorenzo M. J. JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3. Arch Biochem Biophys. 2017. № 15. V. 636. P. 42-49.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lou M., Zhang L. N., Ji P. G., Feng F. Q., Liu J. H., Yang C., Li B. F., Wang L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3signaling pathway in human neuroglioma cells: In vitro and in vivo, Biomed Pharmacother. 2016. V. 84. P. 1-9.</mixed-citation><mixed-citation xml:lang="en">Lou M., Zhang L. N., Ji P. G., Feng F. Q., Liu J. H., Yang C., Li B. F., Wang L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3signaling pathway in human neuroglioma cells: In vitro and in vivo, Biomed Pharmacother. 2016. V. 84. P. 1-9.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Liu R., Shih T.-C., Deng X., Anwar L., Ahadi S., Kumaresan P., Lam K. S. Design, Synthesis, and Application of OB2C Combinatorial Peptide and Peptidomimetic Libraries, Methods Mol. Biol. 2015. V. 1248. P. 3-22.</mixed-citation><mixed-citation xml:lang="en">Liu R., Shih T.-C., Deng X., Anwar L., Ahadi S., Kumaresan P., Lam K. S. Design, Synthesis, and Application of OB2C Combinatorial Peptide and Peptidomimetic Libraries, Methods Mol. Biol. 2015. V. 1248. P. 3-22.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Allaman-Pillet N., Oberson A., Schorderet D. F., BIRO1, a Cell-Permeable BH3 Peptide, Promotes Mitochondrial Fragmentation and Death of Retinoblastoma Cells, Mol. Cancer Res. 2015. V. 13. №1. P. 86-97.</mixed-citation><mixed-citation xml:lang="en">Allaman-Pillet N., Oberson A., Schorderet D. F., BIRO1, a Cell-Permeable BH3 Peptide, Promotes Mitochondrial Fragmentation and Death of Retinoblastoma Cells, Mol. Cancer Res. 2015. V. 13. №1. P. 86-97.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Russo P., Arzani D., Trombino S., Falugi C. С-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor, The journal of pharmacology and experimental therapeutics. 2003. V. 304. P. 37-47.</mixed-citation><mixed-citation xml:lang="en">Russo P., Arzani D., Trombino S., Falugi C. С-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor, The journal of pharmacology and experimental therapeutics. 2003. V. 304. P. 37-47.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
